Olema Oncology Is A Clinical Stage Biopharmaceutical Company Based In San Franciscocaliforniathe Company Is Dedicated To Developing Targeted Therapies For Breast Cancer And Other Cancerswith A Strong Emphasis On Improving Patient Care For Metastatic Breast Cancerolema S Team Is Driven By Personal Connections To The Disease And Possesses Extensive Expertise In Oncology Drug Development The Company S Key Productpalazestrantop 1250 Is Currently In Phase 3 Trials For Metastatic Breast Cancerthis Includes The Opera 01 Trialwhich Is A Pivotal Study For Second And Third Line Treatmentand The Opera 02 Trialwhich Combines Palazestrant With Ribociclib For Frontline Treatmentadditionallyolema Is Developing Op 3136A Kat6 Inhibitor That Has Shown Preclinical Anti Tumor Activity In Various Solid Tumor Modelsolema Collaborates With Novartis To Explore Combinations Of Their Therapiesenhancing Their Research Capabilities Recognized As A Great Place To Workain 2025Olema Fosters A Mission Driven Culturesupported By A Leadership Team With Significant Experience In The Biopharmaceutical Industry
No conferences found for this company.
| Company Name | Olema Pharmaceuticals Inc |
| Country |
United States
|
| Address | 512 2nd St 4th Floor San Francisco Ca 94107 |
| Telephone | Login to View |
| Login to View |
